Streptozotocin

Intervention

357 papers mention it18 findings

PubChemChEBI

Research on it is growing about as fast as aging research as a whole: 101 papers in the latest year counted

29 new papers in 30 daysSee all 357 papers on streptozotocin

At a glance

The findings reach mice, none yet in people; independent labs found the same change in mice. 7 independent labs in 6 countries; 8 trials, 5 with no results posted.

None of its findings points the other way.

Mice: replicated by independent labs. Cells, worms or flies and humans: nothing yet.
  • 7 independent labs in 6 countries
  • 8 trials, 5 with no results posted
  • Funders: Emberi Eroforrások Minisztériuma and others
  • 2 of 18 findings with company ties

What did studies of streptozotocin find?

17

Studies of streptozotocin measured 17 outcomes, among them cellular senescence, senescence-associated secretory phenotype (SASP) and ER unfolded protein response.

Cellular senescence

upin rats2

2 studies
  1. Streptozotocin induces cellular senescence in rats (measured by p53, p21 and p16 in cultured astrocytes from STZ-ICV-treated rats).

    “When evaluating senescence parameters, increases in p53, p21, and p16 were observed”

    Animalsmeasured by p53, p21 and p16 in cultured astrocytes from STZ-ICV-treated ratshypothalamic astrocytesfour weeksmales

    The Senescent Phenotype of Cultured Hypothalamic Astrocytes from Rats with Streptozotocin-Induced Dementia

    Neurochemical research

  2. Streptozotocin increases cellular senescence in DKD rats.

    “In DKD rats and HK-2 cells, p21, p53, LC3 and p62 expression levels were higher than in the controls, as were SA-β-gal-positive cells, renal tubular autophagosomes”

    Animalsin DKD ratskidney

    High glucose induces renal tubular epithelial cell senescence by inhibiting autophagic flux

    Human cell

More on Cellular senescence

Senescence-associated secretory phenotype (SASP)

upin rats1

1 study
  1. Streptozotocin induces senescence-associated secretory phenotype (SASP) in rats (astrocytes cultured from STZ-ICV-treated rats).

    “modulations in TNFα and extracellular HMGB1 and S100B levels also suggested the induction of a senescent profile”

    Animalsastrocytes cultured from STZ-ICV-treated ratshypothalamic astrocytesfour weeksmales

    The Senescent Phenotype of Cultured Hypothalamic Astrocytes from Rats with Streptozotocin-Induced Dementia

    Neurochemical research

More on Senescence-associated secretory phenotype (SASP)

ER unfolded protein response

upin rats1

1 study
  1. Streptozotocin increases ER unfolded protein response in rats (astrocytes cultured from STZ-ICV-treated rats).

    “Markers of unfolded protein response (CHOP and sorcin) were also increased in astrocytes from STZ animals.”

    Animalsastrocytes cultured from STZ-ICV-treated ratshypothalamic astrocytesfour weeksmales

    The Senescent Phenotype of Cultured Hypothalamic Astrocytes from Rats with Streptozotocin-Induced Dementia

    Neurochemical research

More on ER unfolded protein response

Glutamine synthetase

downin rats1

1 study
  1. Streptozotocin decreases glutamine synthetase in rats (astrocytes cultured from STZ-ICV-treated rats).

    “astrocyte cultures exhibited reduced levels of glutamine synthetase and glutathione”

    Animalsastrocytes cultured from STZ-ICV-treated ratshypothalamic astrocytesfour weeksmales

    The Senescent Phenotype of Cultured Hypothalamic Astrocytes from Rats with Streptozotocin-Induced Dementia

    Neurochemical research

More on Glutamine synthetase

CDKN2A

upin mice1

1 study
  1. Streptozotocin increases CDKN2A in STZ-induced diabetic mice.

    “Molecular analyses revealed significant upregulation of MCP-1 and p16INK4a at mRNA and protein levels.”

    Animalsin STZ-induced diabetic miceretina

    Retinal Ganglion Cell Senescence Links Diabetes to Retinal Neurodegeneration

    Cureus

More on CDKN2A

Retinal neural function

downin mice1

1 study
  1. Streptozotocin impairs retinal neural function in STZ-induced diabetic mice.

    “ERG revealed markedly reduced amplitudes of the a-wave, b-wave, and oscillatory potentials, indicating impaired retinal neural function.”

    Animalsin STZ-induced diabetic miceretina

    Retinal Ganglion Cell Senescence Links Diabetes to Retinal Neurodegeneration

    Cureus

Tau phosphorylation

upin mice1

1 study
  1. Streptozotocin increases tau phosphorylation in 3xTg-AD mice.

    “exhibiting an increase in both tau phosphorylation and aggregation without significantly affecting amyloid pathology”

    Animalsin 3xTg-AD miceintraperitoneal

    Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice

    Neurobiology of disease

More on Tau phosphorylation

Tau aggregation

upin mice1

1 study
  1. Streptozotocin increases tau aggregation in 3xTg-AD mice.

    “resulting in an increase in cortical amyloid-β (Aβ) and tau aggregation, while tau phosphorylation was not significantly affected”

    Animalsin 3xTg-AD miceintraperitonealcortex

    Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice

    Neurobiology of disease

More on Tau aggregation

Cortical amyloid-β

upin mice1

1 study
  1. Streptozotocin increases cortical amyloid-β in 3xTg-AD mice.

    “STZ administration led to insulin deficiency in the younger mice, resulting in an increase in cortical amyloid-β (Aβ) and tau aggregation”

    Animalsin 3xTg-AD miceintraperitonealcortex

    Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice

    Neurobiology of disease

More on Cortical amyloid-β

Atherosclerosis

upin mice1

1 study
  1. Streptozotocin increases atherosclerosis in aged ApoE-/- mice.

    “Streptozocin (STZ) aggravates diabetic atherosclerosis in aged ApoE-/- mice.”

    Animalsin aged ApoE-/- miceintraperitoneal injectionaorta50 mg/kg/day5 days consecutivelyn = 6

    Diabetic status aggravates atherosclerosis in aged ApoE-/- mice

    Animal models and experimental medicine

More on Atherosclerosis

All 17

Trial sponsors

Latest

Dec 2025: 5Jan 2026: 18Feb 2026: 11Mar 2026: 17Apr 2026: 7May 2026: 0Jun 2026: 6Jul 2026: 4Aug 2026: 6Sep 2026: 6Oct 2026: 16Nov 2026: 14110 papers in 12 months
Phytomedicine

Compound reduced kidney injury in mice with diabetes

Experiments in mice with diabetes-induced kidney disease found less kidney tubule cell senescence, a state in which cells stop dividing, after receiving procyanidin C1.Experiments in mice with diabetes-induced kidney disease found less kidney tubule cell senescence, a state in which cells stop dividing, after receiving procyanidin C1.

Mouse studyKidney injury
bioRxiv

Drug improved the heart’s natural pacemaker function in rats

At the acute endpoint, efsubaglutide alfa raised heart rate to 372.76 beats per minute versus 312.64 in rats with pacemaker dysfunction without the drug.At the acute endpoint, efsubaglutide alfa raised heart rate to 372.76 beats per minute versus 312.64 in rats with pacemaker dysfunction without the drug.

Preprint: rat studyInterventions

See all 357 papers on streptozotocin